The Role of Trip10 in Cancer Cell Growth
Author Information
Author(s): Hsu Chia-Chen, Leu Yu-Wei, Tseng Min-Jen, Lee Kuan-Der, Kuo Tzen-Yu, Yen Jia-Yi, Lai Yen-Ling, Hung Yi-Chen, Sun Wei-Sheng, Chen Chien-Min, Chu Pei-Yi, Yeh Kun-Tu, Yan Pearlly S, Chang Yu-Sun, Huang Tim H-M, Hsiao Shu-Huei
Primary Institution: National Chung Cheng University
Hypothesis
Trip10 functions as a tumor suppressor and may be involved in the malignancy of ER-negative breast cancer.
Conclusion
Trip10 regulates cancer cell growth and death in a cancer type-specific manner.
Supporting Evidence
- Trip10 is hypermethylated in brain tumor and breast cancer, but hypomethylated in liver cancer.
- Overexpression of Trip10 promoted colony formation in IMR-32 cells but suppressed it in CP70 cells.
- Trip10 expression is regulated by DNA methylation and histone modification in a cell type-specific manner.
Takeaway
Trip10 is a protein that can help or hurt cancer cells depending on the type of cancer. In some cancers, it helps cells grow, while in others, it makes them die.
Methodology
We used methylation-specific PCR and bisulfite sequencing to analyze DNA methylation of Trip10 in various cancer cell lines and tumor specimens, and overexpressed Trip10 to observe its effects on colony formation and tumorigenesis.
Potential Biases
Potential bias in the selection of cancer cell lines and tumor specimens used for analysis.
Limitations
The study may not account for all cancer types and the specific mechanisms of Trip10's action in each type.
Participant Demographics
The study involved various cancer cell lines and human tumor specimens, including breast cancer, liver cancer, brain tumors, and ovarian cancer.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website